Defining and understanding the "extra-corporeal membrane oxygenation gap" in the veno-venous configuration: Timing and causes of death.

Previous and recent multicenter, randomized controlled trials showed a trend towards reduced mortality in favor of V‐V ECMO over conventional treatment. 6 , 7 Furthermore, in a recently published meta‐analysis of these trials, 60‐day mortality was significantly lower in the V‐V ECMO group. 8 Although mortality rates in V‐V ECMO are lower compared with other ECMO modalities, a substantial quote of patients still die during hospital admittance. 9 According to the Extracorporeal Life Support Organization (ELSO), more than 75 000 ECMO runs for respiratory compromise have been performed in more than 450 centers (as of July 2021).

also in 53,322 other papers